Search results for " Biopharm"
Article
Evolution of the Monoclonal Antibody Purification Platform
Monoclonal antibodies (mAb) increasingly form the majority share of the product pipeline, as well as revenue, of major biopharmaceutical companies (1). What is unique about mAbs from a processing pers…
Article
Report from India
Tapan Ray, director general of the Organization of Pharmaceutical Producers of India (OPPI), said in an interview with BioPharm International, "Ceiling prices will now be based on approximately 91% of…
Article
PDA's Technical Report for Biotech Cleaning Validation
Cleaning validation plays an important role in reducing the possibility of product contamination from biopharmaceutical manufacturing equipment. It demonstrates that the cleaning process adequately an…
About
Articles and App Notes
Peer-reviewed articles from BioPharm International and application notes from Cytiva
Posters
Access to poster presentations by Cytiva
Multimedia
…
Article
Advances in Sterilization Technologies for Overcoming Viral-Vector Manufacturing Challenges
Variability challenges
“Sterile manufacturing of live viral vectors used to be the ultimate challenge in the biopharmaceutical industry,” Heller continues. Today, however, the variable nature of vi…
Article
Discovering the unknown: How does in silico process development change PD scientists’ work?
…ver again?
Transcript
Jeanne Linke Northrop: Hello, I'm Jeanne Linke Northrop with BioPharm international. I'm joined today by Nora Ketterer, Manager of Modeling Services, Cytiva. N…
Article
Weighing the Benefits of Single-Use Consumables
…ment?
BioPharm International spoke with SUS experts Nick Johnson, director of Product Management, Biopharma, CPC; Wolfgang Walcher, chief commercial officer, Single Use Support (at the time of int…
Article
What’s in your media? How costly is variability of cell culture media to your manufacturing process?
I am Megan Manzano, senior editor for BioPharm Interantional. Joining me today is Christopher Woolstenhulme, lead analytical scientist of manufacturing sciences at Cytiva. Thank you so much for being …
Article
Pandemic Alters Policies and Practices for Drug Development and Regulation
The desperate need for new vaccines and therapies to tame the deadly COVID-19 virus required new policies and procedures for how biopharma companies select, test, and manufacture medical products—and …
Article
Track-and-Trace Progress Benefits Supply-Chain Security Efforts
In April 2021, Tive, Persequor, and Itrazo joined forces in a similar collaboration designed to help improve traceability in the cold chain, with an emphasis on biopharmaceuticals. “With the COVID-19 …